{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:16:29Z","timestamp":1760660189845,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ejim.2021.11.012","type":"journal-article","created":{"date-parts":[[2021,11,22]],"date-time":"2021-11-22T18:47:41Z","timestamp":1637606861000},"page":"1-3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The 2021 ESC guidelines on cardiovascular prevention: Whether the ends justify the means"],"prefix":"10.1016","volume":"97","author":[{"given":"Claudio","family":"Cimminiello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charalambos","family":"Vlachopulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"De Carlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2021.11.012_bib0001","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2021.11.012_bib0002","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2021.11.012_bib0003","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet","volume":"368","author":"Estruch","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2021.11.012_bib0004","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jacc.2017.06.054","article-title":"Relationship of alcohol consumption to all-cause, cardiovascular, and cancer-related mortality in U.S. adults","volume":"70","author":"Xi","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2021.11.012_bib0005","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1111\/add.14703","article-title":"Alcohol use disorders and the heart","volume":"114","author":"Day","year":"2019","journal-title":"Addiction"},{"key":"10.1016\/j.ejim.2021.11.012_bib0006","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nrcardio.2015.91","article-title":"Cardiovascular risks and benefits of moderate and heavy alcohol consumption","volume":"12","author":"Fernandez-Sola","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.ejim.2021.11.012_bib0007","doi-asserted-by":"crossref","first-page":"g4164","DOI":"10.1136\/bmj.g4164","article-title":"Association between alcohol and cardiovascular disease: mendelian randomisation analysis based on individual participant data","volume":"349","author":"Holmes","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2021.11.012_bib0008","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(18)31772-0","article-title":"Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China","volume":"393","author":"Millwood","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2021.11.012_bib0009","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(18)30134-X","article-title":"Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies","volume":"391","author":"Wood","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2021.11.012_bib0010","doi-asserted-by":"crossref","first-page":"14788","DOI":"10.3390\/ijms131114788","article-title":"Phosphatidylethanol in blood as a marker of chronic alcohol use: a systematic review and meta-analysis","volume":"13","author":"Viel","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejim.2021.11.012_bib0011","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.clnu.2020.02.009","article-title":"Drink types unmask the health risks associated with alcohol intake - Prospective evidence from the general population","volume":"39","author":"Schutte","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.ejim.2021.11.012_bib0012","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2021.11.012_bib0013","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1161\/CIRCULATIONAHA.118.037885","article-title":"Age at diagnosis of type 2 diabetes mellitus and associations with cardiovascular and mortality risks","volume":"139","author":"Sattar","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2021.11.012_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001321","article-title":"Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: scottish registry linkage study","volume":"9","author":"Livingstone","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/j.ejim.2021.11.012_bib0015","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2021.11.012_bib0016","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2021.11.012_bib0017","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174,000 participants in 27 randomised trials","volume":"385","author":"Fulcher","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2021.11.012_bib0018","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","author":"Kearney","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2021.11.012_bib0019","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jama.2015.7008","article-title":"Association of cardiometabolic multimorbidity with mortality","volume":"314","author":"Di Angelantonio","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2021.11.012_bib0020","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2337\/dc05-2465","article-title":"Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the treating to new targets (TNT) study","volume":"29","author":"Shepherd","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejim.2021.11.012_bib0021","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2021.11.012_bib0022","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.atherosclerosis.2015.05.007","volume":"241","author":"Vlachopoulos","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejim.2021.11.012_bib0023","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jacc.2013.09.063","article-title":"Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects","volume":"63","author":"Ben-Shlomo","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2021.11.012_bib0024","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1001\/jamainternmed.2013.3018","article-title":"Bias in associations of emerging biomarkers with cardiovascular disease","volume":"173","author":"Tzoulaki","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ejim.2021.11.012_bib0025","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1161\/HYPERTENSIONAHA.121.17579","article-title":"SPARTE study: normalization of arterial stiffness and cardiovascular events in patients with hypertension at medium to very high risk","volume":"78","author":"Laurent","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.ejim.2021.11.012_bib0026","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/eurheartj\/ehx095","volume":"39","author":"Aboyans","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2021.11.012_bib0027","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1093\/eurheartj\/ehaa621","article-title":"Cardiologists should not lose their peripheral vision: a plea against 'peri-anopsy' in cardiology","volume":"41","author":"Aboyans","year":"2020","journal-title":"Eur Heart J"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620521003861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620521003861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:36:49Z","timestamp":1760607409000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620521003861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":27,"alternative-id":["S0953620521003861"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2021.11.012","relation":{},"ISSN":["0953-6205"],"issn-type":[{"type":"print","value":"0953-6205"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 2021 ESC guidelines on cardiovascular prevention: Whether the ends justify the means","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2021.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}